Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Utbildning och Vård Koncern Sverige AB in connection with the sale of Baggium Vård & Behandling Aktiebolag
Mandate

Vinge advises Utbildning och Vård Koncern Sverige AB in connection with the sale of Baggium Vård & Behandling Aktiebolag

June 13, 2011

Vinge has advised Utbildning och Vård Koncern Sverige AB in connection with the sale of Baggium Vård & Behandling Aktiebolag. Baggium AB has disposed of Baggium Vård & Behandling Aktiebolag which owns and operates 14 units to the Humana group. The operations have an approximate turnover of SEK 130 million with 125 employees and 140 students. Humana’s competence and experience in providing support for, and service to, children and young persons with special needs will provide the right conditions to develop the operations.
The Vinge team that advised Utbildning och Vård Koncern Sverige AB consisted of Petter Kjöllerström (project manager), Fabian Ekeblad (responsible partner), and associates Louise Markgren, Viveka Linander, Anders Frick, Linnéa Blommé, Julia Nordgren and project assistant Annika Johnson

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026